This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fuhr, U Articles by Staib, A H Search for Related Content PubMed PubMed Citation Articles by Fuhr, U Articles by Staib, A H

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1992 May; 36(5): 942-948

Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro.

U Fuhr, E M Anders, G Mahr, F Sörgel and A H Staib

Department of Clinical Pharmacology, University Hospital Frankfurt, Federal Republic of Germany.

ABSTRACT

Inhibition of cytochrome P450IA2 activity is an important adverse effect of quinolone antibacterial agents. It results in a prolonged half-life for some drugs that are coadministered with quinolones, such as theophylline. The objective of the study described here was to define the parameters for quantifying the inhibitory potencies of quinolones against cytochrome P450IA2 in vivo and in vitro and to investigate the relationship between the results of both approaches. Cytochrome P450IA2 activity in vitro was measured by using the 3-demethylation rate of caffeine (500 microM) in human liver microsomes. The inhibitory potency of a quinolone in vitro was determined by calculating the decrease in the activity of cytochrome P450IA2 caused by addition of the quinolone (500 microM) into the incubation medium. The mean values (percent reduction of activity without quinolone) were as follows: enoxacin, 74.9%; ciprofloxacin, 70.4%; nalidixic acid, 66.6%; pipemidic acid, 59.3%; norfloxacin, 55.7%; lomefloxacin, 23.4%; pefloxacin, 22.0%; amifloxacin, 21.4%; difloxacin, 21.3%; ofloxacin, 11.8%; temafloxacin, 10.0%; fleroxacin, no effect. The inhibitory potency of a quinolone in vivo was defined by a dose- and bioavailability-normalized parameter calculated from changes of the elimination half-life of theophylline and/or caffeine reported in previously published studies. Taking the pharmacokinetics of the quinolones into account, it was possible to differentiate between substances with and without clinically relevant inhibitory effects by using results of in vitro investigations. The in vitro test described here may help to qualitatively predict the relevant drug interactions between quinolones and methylxanthines that occur during therapy.

---

Antimicrob Agents Chemother. 1992 May; 36(5): 942-948

This article has been cited by other articles:

• Randinitis, E. J., Alvey, C. W., Koup, J. R., Rausch, G., Abel, R., Bron, N. J., Hounslow, N. J., Vassos, A. B., Sedman, A. J. (2001). Drug Interactions with Clinafloxacin. Antimicrob. Agents Chemother. 45: 2543-2552 [Abstract] [Full Text]  
• Ball, P. (2000). Quinolone generations: natural history or natural selection?. J Antimicrob Chemother 46: 17-24 [Abstract] [Full Text]  
• Takanaga, H., Ohnishi, A., Yamada, S., Matsuo, H., Morimoto, S., Shoyama, Y., Ohtani, H., Sawada, Y. (2000). Polymethoxylated Flavones in Orange Juice Are Inhibitors of P-glycoprotein but Not Cytochrome P450 3A4. J. Pharmacol. Exp. Ther. 293: 230-236 [Abstract] [Full Text]  
• Kiriyama, A., Nishiura, T., Yamaji, H., Takada, K. (1999). Metabolic Characterization of a Tripeptide Human Immunodeficiency Virus Type 1 Protease Inhibitor, KNI-272, in Rat Liver Microsomes. Antimicrob. Agents Chemother. 43: 549-556 [Abstract] [Full Text]  
• Sinués, B., Sáenz, M. A., Lanuza, J., Bernal, M. L., Fanlo, A., Juste, J. L., Mayayo, E. (1999). Five Caffeine Metabolite Ratios to Measure Tobacco-induced CYP1A2 Activity and Their Relationships with Urinary Mutagenicity and Urine Flow. Cancer Epidemiol. Biomarkers Prev. 8: 159-166 [Abstract] [Full Text]  
• Kinzig-Schippers, M., Fuhr, U., Cesana, M., Müller, C., Staib, A. H., Rietbrock, S., Sörgel, F. (1998). Absence of Effect of Rufloxacin on Theophylline Pharmacokinetics in Steady State. Antimicrob. Agents Chemother. 42: 2359-2364 [Abstract] [Full Text]  
• Niki, Y., Itokawa, K., Okazaki, O. (1998). Effects of DU-6859a, a New Quinolone Antimicrobial, on Theophylline Metabolism in In Vitro and In Vivo Studies. Antimicrob. Agents Chemother. 42: 1751-1755 [Abstract] [Full Text]  
• Bloomer, J. C., Clarke, S. E., Chenery, R. J. (1997). In vitro Identification of the P450 Enzymes Responsible for the Metabolism of Ropinirole. Drug Metab. Dispos. 25: 840-844 [Abstract] [Full Text]  
• Goldberg, R. J. (1996). The P-450 System: Definition and Relevance to the Use of Antidepressants in Medical Practice. Arch Fam Med 5: 406-412 [Abstract]